In addition, PC incidence has been influenced by widespread opportunistic PSA testing, demonstrated by the steep increase in incidence observed in Norway from the 1990s marking introduction of the PSA test and the beginning of the “PSA era” (9–11). The gene discussed is KLK3; the disease is pachyonychia congenita.